Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-15 Sale |
2025-04-16 3:22 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $106.4 | $266,000 | 168,174 (Direct) |
View |
2025-03-17 Sale |
2025-03-18 4:37 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $110.53 | $276,325 | 170,674 (Direct) |
View |
2025-03-10 Sale |
2025-03-12 6:41 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
17,929 | $118.17 | $2,118,696 | 301,335 (Direct) |
View |
2025-02-18 Purchase |
2025-02-20 7:42 pm |
Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC. 10% Owner |
1,363,636 | $11 | $14,999,996 | 31,424,760 (Direct) |
View |
2025-02-18 Sale |
2025-02-19 4:43 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $104.09 | $260,225 | 169,061 (Direct) |
View |
2025-02-12 Sale |
2025-02-13 9:13 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
137,676 | $102.22 | $14,073,241 | 267,667 (Direct) |
View |
2025-01-31 Sale |
2025-02-03 6:09 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
142,180 | $97.22 | $13,822,740 | 234,563 (Direct) |
View |
2025-01-15 Sale |
2025-01-16 3:31 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $91.35 | $228,375 | 129,873 (Direct) |
View |
2024-12-19 Purchase |
2024-12-23 8:26 pm |
ASSEMBLY BIOSCIENCES INC. | ASMB | GILEAD SCIENCES INC. 10% Owner |
940,499 | $21.37 | $20,098,464 | 2,209,471 (Direct) |
View |
2024-12-18 Purchase |
2024-12-19 4:19 pm |
Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner |
1,759,978 | $1.04 | $1,830,377 | 19,080,717 (Direct) |
View |
2024-12-16 Sale |
2024-12-17 5:27 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
8,500 | $91.96 | $781,660 | 132,373 (Direct) |
View |
2024-11-29 Sale |
2024-12-03 2:43 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
248,645 | $92.76 | $23,065,271 | 269,779 (Direct) |
View |
2024-11-27 Sale |
2024-11-29 8:10 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
164,211 | $91.92 | $15,094,013 | 145,373 (Direct) |
View |
2024-11-26 Sale |
2024-11-27 6:14 pm |
GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director |
6,788 | $91.39 | $620,356 | 20,650 (Direct) |
View |
2024-11-06 Sale |
2024-11-07 4:38 pm |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
5,000 | $91.28 | $456,400 | 73,127 (Direct) |
View |
2024-11-06 Sale |
2024-11-07 4:32 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
25,590 | $91.5 | $2,341,485 | 221,269 (Direct) |
View |
2024-10-01 Sale |
2024-10-02 4:58 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
2,000 | $83.83 | $167,660 | 100,189 (Direct) |
View |
2024-09-12 Sale |
2024-09-13 7:07 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
21,246 | $84.5 | $1,795,287 | 248,859 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-03-20 5:42 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Wilfong Diane E. Interim Corp Controller & CAO |
0 | $0 | 78,965 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 7:15 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
60,110 | $0 | 240,488 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
8,080 | $0 | 240,488 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
3,907 | $117.21 | 240,488 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 7:12 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
208,085 | $0 | 1,000,259 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 7:12 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
24,024 | $0 | 1,000,259 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 7:12 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
11,632 | $117.21 | 1,000,259 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 7:08 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
41,620 | $0 | 127,074 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
3,343 | $0 | 127,074 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
1,130 | $117.21 | 127,074 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 6:41 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
17,929 | $63.91 | 301,335 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 6:41 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
60,110 | $0 | 301,335 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 6:41 pm |
N/A 2031-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
25,897 | $0 | 301,335 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 6:41 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
3,855 | $117.21 | 301,335 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 6:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
1,952 | $0 | 49,328 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 6:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
624 | $117.21 | 49,328 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 6:04 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer |
46,240 | $0 | 95,215 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
26,175 | $57.92 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
77,691 | $63.91 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A 2031-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
137,676 | $0 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
18,210 | $83.49 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
15,600 | $80.72 | 267,667 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:24 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
709 | $0 | 37,787 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:21 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
12,371 | $0 | 34,011 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:18 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
224,504 | $0 | 617,876 (Direct) |
View |
2025-02-04 Tax Withholding |
2025-02-06 4:18 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
108,156 | $97.99 | 617,876 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
90,505 | $0 | 119,979 (Direct) |
View |
2025-02-04 Tax Withholding |
2025-02-06 4:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
45,666 | $97.99 | 119,979 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
84,488 | $0 | 171,223 (Direct) |
View |
2025-02-04 Tax Withholding |
2025-02-06 4:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
43,138 | $97.99 | 171,223 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
26,170 | $57.92 | 234,563 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
44,160 | $65.38 | 234,563 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A 2032-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
142,180 | $0 | 234,563 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
71,850 | $72.34 | 234,563 (Direct) |
View |
2025-01-25 Tax Withholding |
2025-01-27 5:47 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
187 | $93.07 | 49,519 (Direct) |
View |
2025-01-25 Exercise |
2025-01-27 5:47 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
515 | $0 | 49,519 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 6:38 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer |
48,975 | $0 | 48,975 (Direct) |
View |
2024-12-13 Tax Withholding |
2024-12-16 4:22 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
157 | $91.86 | 72,990 (Direct) |
View |
2023-12-13 Tax Withholding |
2024-12-16 4:22 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
298 | $83.09 | 72,990 (Direct) |
View |
2023-12-13 Exercise |
2024-12-16 4:22 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
455 | $0 | 72,990 (Direct) |
View |
2024-12-10 Exercise |
2024-12-11 7:51 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
639 | $0 | 49,706 (Direct) |
View |
2024-12-10 Tax Withholding |
2024-12-11 7:51 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
306 | $92.34 | 49,706 (Direct) |
View |
2024-12-10 Exercise |
2024-12-11 7:48 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
901 | $0 | 49,360 (Direct) |
View |
2024-12-10 Tax Withholding |
2024-12-11 7:48 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
408 | $92.34 | 49,360 (Direct) |
View |
2024-12-10 Exercise |
2024-12-11 7:24 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
3,820 | $0 | 119,603 (Direct) |
View |
2024-12-10 Tax Withholding |
2024-12-11 7:24 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,771 | $92.34 | 119,603 (Direct) |
View |
2024-12-10 Exercise |
2024-12-11 7:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
10,295 | $0 | 606,505 (Direct) |
View |
2024-12-10 Tax Withholding |
2024-12-11 7:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
4,762 | $92.34 | 606,505 (Direct) |
View |
2024-12-10 Exercise |
2024-12-11 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
3,752 | $0 | 111,333 (Direct) |
View |
2024-12-10 Tax Withholding |
2024-12-11 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
1,739 | $92.34 | 111,333 (Direct) |
View |
2024-12-10 Exercise |
2024-12-11 7:05 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
3,640 | $0 | 176,360 (Direct) |
View |
2024-12-10 Tax Withholding |
2024-12-11 7:05 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,686 | $92.34 | 176,360 (Direct) |
View |
2024-11-29 Exercise |
2024-12-03 2:43 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
26,170 | $57.92 | 269,779 (Direct) |
View |
2024-11-29 Exercise |
2024-12-03 2:43 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
109,300 | $72.7 | 269,779 (Direct) |
View |
2024-11-29 Exercise |
2024-12-03 2:43 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
60,885 | $71.91 | 269,779 (Direct) |
View |
2024-11-29 Exercise |
2024-12-03 2:43 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
18,630 | $73.77 | 269,779 (Direct) |
View |
2024-11-29 Exercise |
2024-12-03 2:43 pm |
N/A 2032-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
248,645 | $0 | 269,779 (Direct) |
View |
2024-11-29 Exercise |
2024-12-03 2:43 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
33,660 | $68.75 | 269,779 (Direct) |
View |
2024-11-27 Exercise |
2024-11-29 8:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
57,294 | $57.92 | 145,373 (Direct) |
View |
2024-11-27 Exercise |
2024-11-29 8:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
88,119 | $65.38 | 145,373 (Direct) |
View |
2024-11-27 Exercise |
2024-11-29 8:10 pm |
N/A 2032-03-10 |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
145,413 | $0 | 145,373 (Direct) |
View |
2024-11-26 Exercise |
2024-11-27 6:14 pm |
N/A 2030-12-08 |
GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director |
10,000 | $0 | 20,650 (Direct) |
View |
2024-11-26 Exercise |
2024-11-27 6:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director |
4,121 | $61.35 | 20,650 (Direct) |
View |
2024-11-26 Exercise |
2024-11-27 6:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director |
5,879 | $61.17 | 20,650 (Direct) |
View |
2024-11-06 Exercise |
2024-11-07 4:32 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
25,000 | $57.92 | 221,269 (Direct) |
View |
2024-11-06 Exercise |
2024-11-07 4:32 pm |
N/A 2032-03-10 |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
25,000 | $0 | 221,269 (Direct) |
View |
2024-10-25 Tax Withholding |
2024-10-28 3:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
242 | $89 | 50,012 (Direct) |
View |
2024-10-25 Exercise |
2024-10-28 3:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
514 | $0 | 50,012 (Direct) |
View |
2024-09-12 Exercise |
2024-09-13 7:07 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
25,000 | $57.92 | 248,859 (Direct) |
View |
2024-09-12 Exercise |
2024-09-13 7:07 pm |
N/A 2032-03-10 |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
25,000 | $0 | 248,859 (Direct) |
View |